Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tariff on Q2 2021 Results - Earnings Call Transcript
12:39pm, Monday, 09'th Aug 2021
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tariff on Q2 2021 Results - Earnings Call Transcript
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Surpass Estimates
09:19am, Monday, 09'th Aug 2021
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 5.68% and 1.74%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Eagle Pharmaceuticals Q2 Earnings
07:07am, Monday, 09'th Aug 2021
Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 63.16% year over year to $0.93, which beat the estimate
Eagle Pharmaceuticals Reports Second Quarter 2021 Results
06:50am, Monday, 09'th Aug 2021
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and six months ended June 30, 2021.
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has entered into a licensing agreement with AOP Orphan Phar
New Strong Sell Stocks for June 18th
12:02pm, Friday, 18'th Jun 2021
OEG, EAF, RARE, EGRX, and TELA have been added to the Zacks Rank #5 (Strong Sell) List on June 18, 2021
Eagle Pharmaceuticals: A Potential Reopening Play
01:59pm, Wednesday, 16'th Jun 2021
Eagle Pharmaceuticals has felt the impact of COVID-19, and the earnings reports have reflected that. As a result, the share price has taken a beating over the past year.
New York, New York--(Newsfile Corp. - June 11, 2021) - Levi & Korsinsky announces it has commenced an investigation of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) concerning possible breaches of fiduci
Eagle Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
05:00pm, Wednesday, 26'th May 2021
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chie
New York, New York--(Newsfile Corp. - May 14, 2021) - Levi & Korsinsky announces it has commenced an investigation of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) concerning possible breaches of fiducia
Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference
05:00pm, Tuesday, 11'th May 2021
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chie
Eagle Pharmaceuticals, Inc.'s (EGRX) CEO Scott Tarriff on Q1 2021 Results - Earnings Call Transcript
02:54pm, Monday, 10'th May 2021
Eagle Pharmaceuticals, Inc.'s (EGRX) CEO Scott Tarriff on Q1 2021 Results - Earnings Call Transcript
Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss Estimates
09:01am, Monday, 10'th May 2021
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of -66.67% and -9.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Eagle Pharmaceuticals Q1 Earnings
07:10am, Monday, 10'th May 2021
Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share decreased 71.43% year over year to $0.24, which missed the
Eagle Pharmaceuticals Reports First Quarter 2021 Results
06:50am, Monday, 10'th May 2021
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three months ended March 31, 2021. Busine
